Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography

Head and Neck

Volumn 19, Issue 8, 1997, Pages 666-674

  Lowe, Val J ^a   Dunphy, Frank R ^a   Varvares, Mark ^b   Kim, Han ^a   Wittry, Mark ^a   Dunphy, Cherie H ^b   Dunleavy, Theresa ^a   McDonough, Erin ^b   Minster, Jeffrey ^a   Fletcher, James W ^a   Boyd, James H ^b  

^a SAINT LOUIS UNIVERSITY   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemotherapy; F 18 fluorodeoxyglucose (FDG); Head and neck neoplasms; Positron emission tomography; Treatment monitoring

Indexed keywords

CARBOPLATIN; FLUORODEOXYGLUCOSE F 18; PACLITAXEL;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; MINIMAL RESIDUAL DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR BIOPSY;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOPSY; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030658952     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0347(199712)19:8<666::AID-HED4>3.0.CO;2-3     Document Type: Article

References (17)

1. Kraus DH, Pfister DG, Harrison LB, et al. Larynx preservation with combined chemotherapy and radiation therapy in advanced hypopharynx cancer. Otolaryngol Head Neck Surg 1994;111:31-37.
2. Shirinian MH, Weber RS, Lippman SM, et al. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience. Head Neck 1994;16:39-44.
3. Spaulding MB, Fischer SG, Wolf GT. Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. The Department of Veteran's Affairs Cooperative Laryngeal Cancer Study Group. J Clin Oncol 1994;12:1592-1599.
4. Bailet JW, Abemayor E, Jabour BA, Hawkins RA, Ho C, Ward PH. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope 1992;102:281-288.
5. Lapela M, Grenman R, Kurki T, et al. Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose. Radiology 1995;197:205-211.
6. Laubenbacher C, Saumweber D, Wagner MC, et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 1995;36:1747-1757.
7. Rege S, Maass A, Chaiken L, et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer 1994;73: 3047-3058.
8. Warburg O. The metabolism of tumors. London: Constable, 1930.
9. Weber G. Enzymology of cancer cells. Part I. N Engl J Med 1977;296:468-492.
10. Flier JS, Mueckler MM, Usher P, Lodish HF. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 1987; 235:1492-1495.
11. Gallagher BM, Fowler JS, Gutterson NI, MacGregor RR, Wan CN, Wolf AP. Metabolic trapping as a principle of radiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. J Nucl Med 1978;19:1154-1161.
12. Lowe VJ, Hoffman JM, Delong DM, Patz EF, Coleman RE. Semi-quantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 1994;35: 1771-1776.
13. McGuirt WF, Williams D3, Keyes JJ, et al. A comparative diagnostic study of head and neck nodal metastases using positron emission tomography. Laryngoscope 1995; 105: 373-375.
14. Bailet JW, Sercarz JA, Abemayor E, Anzai Y, Lufkin RB, Hoh CK. The use of positron emission tomography for early detection of recurrent head and neck squamous cell carcinoma in postradiotherapy patients. Laryngoscope 1995;105:135-139.
15. Rege S, Maass A, Chaiken L, et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer 1994;73: 3047-3058.
16. Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses. Radiology 1996;200:135-141.
17. Lowe VJ, Hebert ME, Hawk TC, et al. Chest wall FDG accumulation in serial FDG-PET images in patients being treated for bronchogenic carcinoma with radiation. J Nucl Med (Abstract) 1994;35:76P.